Clinical Trial Update: Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating the safety and efficacy of KAM1403 Gel for radiation dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Dermatitis

Drugs mentioned

• KAM1403 Gel

Snippet

Sponsor: Kamedis Ltd. | Conditions: Radiation Dermatitis | Phase 2 | Status: UNKNOWN